Column - June 1, 2026
Policy cannot be built as an afterthought
As a policy insider who has dealt with the intricacies of life science, I am aware of the challenge of taking a molecule from bench to bedside. It’s an arduous journey that more often than not ends in disappointment. Policy work follows a surprisingly similar trajectory. Years of work for passing a minor legislative change may, in the end, yield little to nothing.
